Rap1GAP exacerbates myocardial infarction by regulating the AMPK/SIRT1/NF- κB signaling pathway

In conclusion, our results suggest that Rap1GAP promotes MI by modulating the AMPK/SIRT1/NF-κB signaling pathway and that Rap1GAP may be a therapeutic target for MI treatment in the future.PMID:38320624 | DOI:10.1016/j.cellsig.2024.111080
Source: Cellular Signalling - Category: Cytology Authors: Source Type: research